Aficamten

CAS No. 2364554-48-1

Aficamten ( CK-3773274 )

Catalog No. M24076 CAS No. 2364554-48-1

Aficamten is a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 170 In Stock
10MG 267 In Stock
25MG 537 In Stock
50MG 767 In Stock
100MG 1053 In Stock
500MG 2115 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aficamten
  • Note
    Research use only, not for human use.
  • Brief Description
    Aficamten is a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.
  • Description
    Aficamten is a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.
  • Synonyms
    CK-3773274
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2364554-48-1
  • Formula Weight
    337.4
  • Molecular Formula
    C18H19N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CN(C)N=C1)N[C@@H]2CCC3=C2C=CC(C4=NOC(CC)=N4)=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BDP-13176

    BDP-13176 is a potent?inhibitor of fascin 1(Kd?of 90 nM and an?IC50?of 240 nM). It has potential as an anti-metastatic agent.

  • Cyclo(Hpro-Leu)

    Cyclo(Hpro-Leu) is a natural product for research related to life sciences.

  • SKI II

    SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.